What Is a Colon Polyp?
Dr. Laura Porter discusses what everyone needs to know about colon and rectal polyps for our Colorectal Cancer Academy series.
Related Topics
Top resources
FDA approves immunotherapy for MSI-H/dMMR stage II & III rectal cancer
The U.S. Food and Drug Administration approved dostarlimab (brand name Jemperli) as the first and only immunotherapy for adults with stage II or III rectal cancer that has a biomarker called MSI-H or dMMR.
Last updated
FDA approves Tecentriq for some people with stage III colon cancer
The FDA has approved Tecentriq (atezolizumab), given with chemotherapy after surgery, for people with stage III colon cancer whose tumors are mismatch repair deficient (dMMR). It’s the first immunotherapy approved for this use.
Last updated
Why I answer the phone: A cancer care navigator's view
Meet Paige Edmonds, a social worker behind the Alliance's helpline — and the personal loss that led her there.
Last updated